These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22831783)

  • 1. Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
    Vidal D; Altés J; Smandia JA
    Actas Dermosifiliogr; 2013 Jan; 104(1):89-90. PubMed ID: 22831783
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus.
    Creel N; Werth V
    J Drugs Dermatol; 2005; 4(2):225-7. PubMed ID: 15776783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications with synthetic antimalarials].
    Huriez C; Desmons F; Gautier G; Dhellemmes
    Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthetic antimalarials and skin].
    Ribrioux A
    Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
    [No Abstract]   [Full Text] [Related]  

  • 5. Pigmented oral mucosa due to quinacrine.
    López-Jornet P; Pons-Fuster A
    N Y State Dent J; 2011 Nov; 77(6):49-51. PubMed ID: 22338819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
    González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
    Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment of cutaneous lupus erythematosus.
    Werth V
    Dermatol Online J; 2001 Feb; 7(1):2. PubMed ID: 11328623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
    Suess A; Sticherling M
    Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J; Achenbach A; Westenberger M; Stadler R
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area.
    Martin TJ; Sharp I
    Br J Oral Maxillofac Surg; 2004 Aug; 42(4):351-3. PubMed ID: 15225957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mepacrine pigmentation in systemic lupus erythematosus. New data from an ultrastructural, biochemical and analytical electron microscopic investigation.
    Leigh IM; Kennedy CT; Ramsey JD; Henderson WJ
    Br J Dermatol; 1979 Aug; 101(2):147-53. PubMed ID: 486320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of a focal oedematous reaction induced by rituximab overlying lupus erythematosus tumidus.
    Bohelay G; Rousset L; Levy A; Arana R; Laroche L; Caux F
    Eur J Dermatol; 2017 Oct; 27(5):542-543. PubMed ID: 28691689
    [No Abstract]   [Full Text] [Related]  

  • 13. Pustuloderma during cutaneous lupus treatment with thalidomide.
    Rúa-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernández G; Rodriguez-Lozano C; De la Rosa P
    Lupus; 1999; 8(3):248-9. PubMed ID: 10342720
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus.
    Geraminejad P; Stone MS; Sontheimer RD
    Lupus; 2004; 13(6):473-7. PubMed ID: 15303576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine-quinacrine association in resistant cutaneous lupus.
    Lipsker D; Piette JC; Cacoub P; Godeau P; Frances C
    Dermatology; 1995; 190(3):257-8. PubMed ID: 7599397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thiazide diuretic-induced subacute cutaneous lupus erythematosus].
    Wollenberg A; Meurer M
    Hautarzt; 1991 Nov; 42(11):709-12. PubMed ID: 1837545
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced subacute cutaneous lupus erythematosus associated with doxorubicin.
    Chen JK; Chen TS; Lim P; Iqbal M
    J Am Acad Dermatol; 2012 Dec; 67(6):e273-5. PubMed ID: 23158635
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
    Wee JS; Natkunarajah J; Marsden RA
    Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
    [No Abstract]   [Full Text] [Related]  

  • 20. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.